{
    "meta": {
        "portal_name": "medicinal-chemistry",
        "language": "en",
        "updated": "20150427"
    },
    "schema": {
        "html:portal": "http://en.recuweb.com/medicinal-chemistry/",
        "graph:videos": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/videos.json",
        "graph:news": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/news.json",
        "graph:blogs": "http://en.recuweb.com/graph/v1.0/medicinal-chemistry/medicinal-chemistry/blogs.json"
    },
    "items": {
        "firstpost.com/2015/04/biocon-files-ipo-prospectus-for-r&d-arm-syngene-to-raise-rs": {
            "title": "Biocon files IPO prospectus for R&D arm Syngene to raise Rs 600 cr - Firstpost...",
            "snippet": "FirstpostBiocon files IPO prospectus for R&D arm Syngene to raise Rs 600 crFirstpostThe public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo...",
            "date": "2015-04-23",
            "categories": "drug-discovery,chemistry,biology",
            "tags": "vivo,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,prospectus,biocon,files,ipo,syngene,public,medicinal,chemistry,biology",
            "recuweb_url": "http://en.recuweb.com/biology/firstpost.com/2015/04/biocon-files-ipo-prospectus-for-r&d-arm-syngene-to-raise-rs",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://firstpost.com/business/corporate-business/biocon-files-ipo-prospectus-for-rd-arm-syngene-to-raise-rs-600-cr-2208072.html"
        },
        "economictimes.indiatimes.com/2015/04/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise": {
            "title": "Biocon surges as company files prospectus for Syngene IPO to raise Rs 600 crore...",
            "snippet": "The public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology, has been much-delayed. The plan has remained unexecuted since 2012...",
            "date": "2015-04-23",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "plan,plan-has-remained,remained,remained-unexecuted,unexecuted,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,syngene,syngene_ipo,ipo,files,files-prospectus,prospectus,biocon,crore,public,medicinal,chemistry,biology,delayed",
            "recuweb_url": "http://en.recuweb.com/biology/economictimes.indiatimes.com/2015/04/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://economictimes.indiatimes.com/markets/ipos/fpos/biocon-surges-as-company-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore/articleshow/47016602.cms"
        },
        "fnno.com/2015/04/buyers-accumulate-shares-of-albany-molecular-research-up-2-0%": {
            "title": "Buyers Accumulate Shares of Albany Molecular Research, Up 2.0%...",
            "snippet": "Albany offers medicinal chemistry, chemical development, analytical chemistry services, and small-scale manufacturing. One of today's notable stocks on the rise is FLIR Systems (NASDAQ:FLIR), up 1.6% to 30...",
            "date": "2015-04-23",
            "categories": "chemistry",
            "tags": "chemical,development,molecular,research,offers,medicinal,chemistry,services",
            "recuweb_url": "http://en.recuweb.com/chemistry/fnno.com/2015/04/buyers-accumulate-shares-of-albany-molecular-research-up-2-0%",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://fnno.com/story/market-movers/331-buyers-accumulate-shares-albany-molecular-research-20-auto-generated"
        },
        "news-medical.net/2015/04/purdue-university-study-sheds-light-on-how-decitabine-drug-reverses-cell": {
            "title": "Purdue University study sheds light on how decitabine drug reverses cell damage...",
            "snippet": "Basudev Chowdhury, a postdoctoral researcher in the department of medicinal chemistry and molecular pharmacology and first author of the study, described the role of decitabine as a text editor that restores meaning to a garbled sentence and...",
            "date": "2015-04-23",
            "categories": "pharmacology,university,chemistry",
            "tags": "described,described-the-role,role,role-of-decitabine,decitabine,decitabine-as-text,text,text-editor,editor,editor-that-restores,restores,restores-meaning,meaning,sentence,molecular,molecular-pharmacology,pharmacology,study,doctoral,doctoral-researcher,researcher,department,basudev,basudev_chowdhury,chowdhury,drug,university,medicinal,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/news-medical.net/2015/04/purdue-university-study-sheds-light-on-how-decitabine-drug-reverses-cell",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://news-medical.net/news/20150423/Purdue-University-study-sheds-light-on-how-decitabine-drug-reverses-cell-damage.aspx"
        },
        "enewspf.com/2015/04/students-from-roosevelt-university-s-class-of-2016-present-pharmacy-enews": {
            "title": "Students From Roosevelt University's Class of 2016 Present Pharmacy... - eNews Park Forest...",
            "snippet": "eNews Park ForestStudents From Roosevelt University's Class of 2016 Present Pharmacy...eNews Park ForestUnder the direction of Roosevelt Assistant Professor of Medicinal Chemistry Sonali Kurup, the students identified the...",
            "date": "2015-04-23",
            "categories": "students,medicinal-chemistry,chemistry,university",
            "tags": "medicinal,medicinal_chemistry,chemistry,professor,pharmacy,university",
            "recuweb_url": "http://en.recuweb.com/university/enewspf.com/2015/04/students-from-roosevelt-university-s-class-of-2016-present-pharmacy-enews",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://enewspf.com/latest-news/school-news/60704-students-from-roosevelt-university-s-class-of-2016-present-pharmacy-research-posters.html"
        },
        "dnaindia.com/2015/04/bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise": {
            "title": "Bio-tech major Biocon files prospectus for Syngene IPO to raise Rs 600 crore...",
            "snippet": "The public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology, has been much-delayed. The plan has remained unexecuted since 2012...",
            "date": "2015-04-22",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "plan,plan-has-remained,remained,remained-unexecuted,unexecuted,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,syngene,syngene_ipo,ipo,files,files-prospectus,prospectus,biocon,crore,public,medicinal,chemistry,biology,delayed",
            "recuweb_url": "http://en.recuweb.com/biology/dnaindia.com/2015/04/bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://dnaindia.com/money/report-bio-tech-major-biocon-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore-2079786"
        },
        "timesofindia.indiatimes.com/2015/04/biocon-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore": {
            "title": "Biocon files prospectus for Syngene IPO to raise Rs 600 crore...",
            "snippet": "The public listing of Syngene, which offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology, has been much-delayed. The plan has remained unexecuted since 2012...",
            "date": "2015-04-22",
            "categories": "pharmacology,toxicology,drug-discovery,chemistry,biology",
            "tags": "plan,plan-has-remained,remained,remained-unexecuted,unexecuted,vivo,vivo-pharmacology,pharmacology,pharmacology-and-toxicology,toxicology,offers,offers-integrated,offers-integrated-drug,integrated,integrated-drug,integrated-drug-discovery,drug,drug-discovery,discovery,discovery-and-development,development,development-services,services,services-with-capabilities,capabilities,ing,raise,syngene,syngene_ipo,ipo,files,files-prospectus,prospectus,biocon,crore,public,medicinal,chemistry,biology,delayed",
            "recuweb_url": "http://en.recuweb.com/biology/timesofindia.indiatimes.com/2015/04/biocon-files-prospectus-for-syngene-ipo-to-raise-rs-600-crore",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://timesofindia.indiatimes.com/business/india-business/Biocon-files-prospectus-for-Syngene-IPO-to-raise-Rs-600-crore/articleshow/47016949.cms"
        },
        "phys.org/2015/04/drug-research-enhanced-by-fragment-screening-libraries": {
            "title": "Drug research enhanced by fragment screening libraries...",
            "snippet": "Credit: Griffith University Generation of fragment screening libraries could enhance the analysis and application of natural products for medicinal chemistry and drug discovery, according to Griffith University's Professor Ronald Quinn. In a paper...",
            "date": "2015-04-22",
            "categories": "university,drug-discovery,credit,chemistry",
            "tags": "professor,university,drug,drug-discovery,discovery,research,medicinal,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/phys.org/2015/04/drug-research-enhanced-by-fragment-screening-libraries",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://phys.org/news/2015-04-drug-fragment-screening-libraries.html"
        },
        "agrinews-pubs.com/2015/04/new-insecticides-offer-safer-more-targeted-mosquito-control-agri-news": {
            "title": "New insecticides offer safer, more targeted mosquito control - Agri News...",
            "snippet": "Agri NewsNew insecticides offer safer, more targeted mosquito controlAgri NewsThe researchers also are taking steps to minimize the risk that the insecticides could bind with human dopamine receptors, said Val Watts, professor of medicinal chemistry...",
            "date": "2015-04-22",
            "categories": "chemistry",
            "tags": "professor,targeted,medicinal,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/agrinews-pubs.com/2015/04/new-insecticides-offer-safer-more-targeted-mosquito-control-agri-news",
            "resource_url": "http://news.google.com/?hl=en&q=medicinal%2Bchemistry&output=atom&nord=1",
            "source_url": "http://agrinews-pubs.com/Content/News/Latest-News/Article/New-insecticides-offer-safer-more-targeted-mosquito-control-/8/6/12482"
        },
        "medicalxpress.com/2015/04/study-illuminates-role-of-cancer-drug-decitabine-in-repairing-damaged-cells": {
            "title": "Study illuminates role of cancer drug decitabine in repairing damaged cells...",
            "snippet": "Basudev Chowdhury, a postdoctoral researcher in the department of medicinal chemistry and molecular pharmacology and first author of the study, described the role of decitabine as a text editor that restores meaning to a garbled sentence and...",
            "date": "2015-04-22",
            "categories": "pharmacology,cancer,chemistry",
            "tags": "described,described-the-role,role,role-of-decitabine,decitabine,decitabine-as-text,text,text-editor,editor,editor-that-restores,restores,restores-meaning,meaning,sentence,molecular,molecular-pharmacology,pharmacology,study,doctoral,doctoral-researcher,researcher,department,basudev,basudev_chowdhury,chowdhury,drug,medicinal,chemistry",
            "recuweb_url": "http://en.recuweb.com/chemistry/medicalxpress.com/2015/04/study-illuminates-role-of-cancer-drug-decitabine-in-repairing-damaged-cells",
            "resource_url": "http://www.bing.com/news/search?first=1&q=medicinal%2Bchemistry&format=RSS&cc=us",
            "source_url": "http://medicalxpress.com/news/2015-04-illuminates-role-cancer-drug-decitabine.html"
        }
    }
}